Enzymatic method for preparation of UDP-galactose

Patent metadata

Field	Value
Publication number	US-11739358-B2
Application number	US-202017755650-A
Country	US
Kind code	B2
Filing date	Sep 30, 2020
Priority date	Nov 5, 2019
Publication date	Aug 29, 2023
Grant date	Aug 29, 2023

Abstract

The present invention relates to an enzyme-catalyzed process for producing UDP-galactose from low-cost substrates uridine monophosphate and D-galactose in a single reaction mixture. The process can be operated (semi)continuously or in batch mode. The process can be extended to uridine as starting material instead of uridine monophosphate. Further, the process can be adapted to produce galactosylated molecules and biomolecules including saccharides, proteins, peptides, glycoproteins or glycopeptides, particularly human milk oligosaccharides (HMO) and (monoclonal) antibodies.

First claim

The invention claimed is:

1. A method for producing uridine 5 ′-diphospho-a-D-galactose comprising the following steps:

A) providing a solution comprising
(i) uridine monophosphate and D-galactose represented by the following formulae

(ii) polyphosphate, and adenosine triphosphate; and
providing a set of enzymes comprising a glucose-1-phosphate uridylyltransferase, a galactokinase, a polyphosphate kinase, and a uridine monophosphate kinase;

B) producing uridine 5 ′-diphospho-α-D-galactose from uridine monophosphate and D-galactose in the presence of the set of enzymes, polyphosphate, and adenosine triphosphate.

2. The method according to claim 1 , wherein the set of enzymes further comprises a pyrophosphatase.

3. The method according to claim 1 , wherein the set of enzymes further comprises a one-domain polyphosphate kinase 2.

4. The method according to claim 1 , wherein the set of enzymes further comprises a two-domain polyphosphate kinase 2.

5. The method according to claim 1 , wherein at least one enzyme of the set of enzymes is immobilized on a solid support.

6. The method according to claim 1 , wherein the set of enzymes is co-immobilized on a solid support.

7. The method according to claim 6 , wherein the set of enzymes is directly co-immobilized on a solid support from fermentation broth, crude cell lysate, purified cell lysate or cell homogenate.

8. The method according to claim 1 , wherein the concentration of uridine monophosphate and D-galactose in the solution provided in A) is in the range of 0.2 mM to 15,000 mM.

9. The method according to claim 1 , wherein the polyphosphate is a long-chain polyphosphate having at least 25 phosphate residues.

10. The method according to claim 1 , wherein the uridine 5′-diphospho-α-D-galactose is produced in a single reaction mixture.

11. The method according to claim 1 , wherein the uridine monophosphate in A) is obtained from uridine, adenosine triphosphate and a uridine kinase; or from uracil, 5-phospho-α-D-ribose 1-diphosphate and a uracil phosphoribosyltransferase; or from orotic acid, 5-phospho-α-D-ribose 1-diphosphate, an orotate phosphoribosyltransferase and a UMP transferase.

12. The method according to claim 1 , further comprising
producing a galactosylated saccharide, galactosylated glycopeptide, galactosylated glycoprotein galactosylated protein, galactosylated peptide, galactosylated bioconjugate or galactosylated small molecule from uridine 5′-diphospho-α-D-galactose and a saccharide, glycopeptide, glycoprotein, protein, peptide, bioconjugate or small molecule by forming an O-glycosidic bond between uridine 5′-diphospho-α-D-galactose and an available hydroxyl group of the saccharide, glycopeptide, glycoprotein, protein, peptide, bioconjugate or small molecule in the presence of a galactosyltransferase.

13. The method according to claim 12 , wherein the saccharide, glycopeptide, glycoprotein, protein, peptide, bioconjugate or small molecule is an antibody or a monoclonal antibody; or a human milk oligosaccharide or a bioconjugate.

14. The method according to claim 12 , further comprising recycling of uridine diphosphate formed from the producing a GlcNAcylated saccharide, a GlcNAcylated glycopeptide, a GlcNAcylated glycoprotein, a GlcNAcylated protein, a GlcNAcylated peptide, a GlcNAcylated bioconjugate or a GlcNAcylated small molecule from uridine 5′-diphospho-N-acetylglucosamine and a saccharide, glycopeptide, glycoprotein, protein, peptide, bioconjugate or small molecule by forming an O-glycosidic bond between uridine 5′-diphospho-N-acetylglucosamine and an available hydroxyl group of the saccharide, glycopeptide, glycoprotein, protein, peptide, bioconjugate or small molecule in the presence of an N-acetylglucosaminyltransferase to obtain uridine triphosphate.

15. The method according to claim 12 , wherein the saccharide, glycopeptide, glycoprotein, protein, peptide, bioconjugate or small molecule is a carbohydrate conjugate vaccine or an antibody drug conjugate.

Assignees

• Max Planck Gesellschaft

Inventors

• Mahour Reza
• Rexer Thomas F T

Classifications

• C12P19/305 Primary

  Pyrimidine nucleotides · CPC title

• C12N9/1205

  Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases · CPC title

• C12N9/1229

  Phosphotransferases with a phosphate group as acceptor (2.7.4) · CPC title

• C12N9/1241

  Nucleotidyltransferases (2.7.7) · CPC title

• C12Y207/01006

  Galactokinase (2.7.1.6) · CPC title